Prebiotics: Why definitions matter

Current Opinion in Biotechnology

Volumn 37, Issue , 2016, Pages 1-7

  Hutkins, Robert W ^a   Krumbeck, Janina A ^a,b   Bindels, Laure B ^c   Cani, Patrice D ^c   Fahey, George ^d   Goh, Yong Jun ^e   Hamaker, Bruce ^f   Martens, Eric C ^g   Mills, David A ^h   Rastal, Robert A ⁱ   Vaughan, Elaine ^j   Sanders, Mary Ellen ^k  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UNIVERSITY OF NEBRASKA   (United States)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^e NORTH CAROLINA STATE UNIVERSITY   (United States)

^f PURDUE UNIVERSITY   (United States)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF READING   (United Kingdom)

^j Sensus BV (Royal Cosun)   (Netherlands)

^k DAIRY AND FOOD CULTURE TECHNOLOGIES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CONTINUED USE; FOOD INDUSTRIES; GLYCOMICS; GUT MICROBIOTA; HEALTH CARE PROFESSIONALS; PREBIOTICS; REGULATORY AGENCIES; SCIENTIFIC COMMUNITY;

BIOTECHNOLOGY;

PREBIOTIC AGENT; PROBIOTIC AGENT;

BIFIDOBACTERIUM; CONSUMER; FOOD INDUSTRY; GLYCOBIOLOGY; HEALTH PRACTITIONER; HUMAN; IN VITRO STUDY; INTESTINE FLORA; LACTOBACILLUS; METABOLISM; METABOLOMICS; METAGENOMICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; COMMUNITY PARTICIPATION;

ANIMALS; COMMUNITY PARTICIPATION; FOOD INDUSTRY; GASTROINTESTINAL MICROBIOME; HUMANS; PREBIOTICS;

EID: 84942636270     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2015.09.001     Document Type: Review

References (64)

1. Tanaka R., Takayama H., Morotomi M., Kuroshima T., Ueyama S., Matsumoto K., Kuroda A., Mutai M. Effects of administration of TOS and Bifidobacterium breve 4006 on the human fecal flora. Bifidobact Microflora 1983, 2:17-24.
2. Okazaki M., Fujikawa S., Matsumoto N. Effect of xylooligasaccharide on the growth of bifidobacteria. Bifidobact Microflora 1990, 9:77-86.
3. Ito M., Deuguchi Y., Miyamori A., Matsumote K., Kikuchi H., Matsumoto K., Yajima T., Kan T. Effects of administration of galactooligosaccharides on the human faecal microflora, stool weigh and abdominal sensation. Microb Ecol Health Dis 1990, 3:285-292.
4. Hidaka H., Tashiro Y., Eida T. Proliferation of bifidobacteria by oligosaccharides and their useful effect on human health. Bifidobact Microflora 1991, 10:65-79.
5. György P., Norris R.F., Rose S.R. Bifidus factor. I. A variant of Lactobacillus bifidus requiring a special growth factor. Arch Biochem Biophys 1954, 48:193-201.
6. Coppa G.V., Bruni S., Morelli L., Soldi S., Gabrielli O. The first prebiotics in humans: human milk oligosaccharides. J Clin Gastroenterol 2004, 38(Suppl. 6):S80-S83.
7. Kitaoka M., Tian J., Nishimoto M. Novel putative galactose operon involving lacto-N-biose phosphorylase in Bifidobacterium longum. Appl Environ Microbiol 2005, 71:3158-3162.
8. Holsinger V.H. Lactose. Fundamentals of dairy chemistry 1988, 279-342. Van Nostrand Reinhold Co., New York, NY, USA. 3rd ed. N.P. Wong, R. Jenness, M. Keeney, E.H. Marth (Eds.).
9. Rettger L.F., Cheplin H.A. A treatise on the transformation of the intestinal flora with special reference to implantation of Bacillus acidophilus 1921, Yale University Press, New Haven.
10. Leach J.D., Gibson G.R., Van Loo J. Human evolution, nutritional ecology and prebiotics in ancient diet. Biosci Microflora 2006, 25:1-8.
11. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995, 125:1401-1412.
12. Reid G., Sanders M.E., Gaskins H.R., Gibson G.R., Mercenier A., Rastall R., Roberfroid M., Rowland I., Cherbut C., Klaenhammer T.R. New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol 2003, 37:105-118.
13. Gibson G.R., Probert H.M., Loo J.V., Rastall R.A., Roberfroid M.B. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004, 17:259-275.
14. Pineiro M., Asp N.G., Reid G., Macfarlane S., Morelli L., Brunser O., Kieran T. FAO technical meeting on prebiotics. J Clin Gastroenterol 2008, 42:S156-S159.
15. Gibson G.R., Scott K.P., Rastall R.A., Tuohy K.M., Hotchkiss A., Dubert-Ferrandon A., Garau M., Murphy E.F., Saulnier D., Loh G., Macfarlane S., Delzenne N., Ringel Y., Kozianowski G., Dickmann R., Lenoir-Wijnkook I., Walker C., Buddington R. Dietary prebiotics: current status and new definition. Food Sci Technol Bull: Funct Foods 2010, 7:1-19.
16. Oliver L., Rasmussen H., Gregoire M.B., Chen Y. Health care provider's knowledge, perceptions, and use of probiotics and prebiotics. Top Clin Nutr 2014, 29:139-149.
17. Betz M., Azueta A., Rasmussen H., Gregoire M., Vanderwall C., Witowich G. Knowledge, use and perceptions of probiotics and prebiotics in hospitalised patients. Nutr Diet 2015, In press.
18. Roberfroid M., Gibson G.R., Hoyles L., McCartney A.L., Rastall R., Rowland I., Wolvers D., Watzl B., Szajewska H., Stahl B., Guarner F., Respondek F., Whelan K., Coxam V., Davicco M.J., Léotoing L., Wittrant Y., Delzenne N.M., Cani P.D., Neyrinck A.M., Meheust A. Prebiotic effects: metabolic and health benefits. Br J Nutr 2010, 104:S1-S63.
19. Rastall R.A., Maitin V. Prebiotics and synbiotics: towards the next generation. Curr Opin Biotechnol 2002, 13:490-496.
20. Bird A.R., Conlon M.A., Christophersen C.T., Topping D.L. Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics. Benef Microbes 2010, 1:423-431.
21. Coppa G.V., Zampini L., Galeazzi T., Gabrielli O. Prebiotics in human milk: a review. Dig Liver Dis 2006, 38(Suppl. 2):S291-S294.
22. Rastall R.A., Gibson G.R. Recent developments in prebiotics to selectively impact beneficial microbes and promote intestinal health. Curr Opin Biotechnol 2015, 32:42-46.
23. Gibson G.R., Fuller R. Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. J Nutr 2000, 130:391S-395S.
24. Goh Y.J., Klaenhammer T.R. Genetic mechanisms of prebiotic oligosaccharide metabolism in probiotic microbes. Annu Rev Food Sci Technol 2015, 6:137-156.
25. Everard A., Lazarevic V., Derrien M., Girard M., Muccioli G.G., Neyrinck A.M., Possemiers S., Van Holle A., François P., de Vos W.M., Delzenne N.M., Schrenzel J., Cani P.D. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011, 60:2775-2786.
26. Everard A., Lazarevic V., Gaïa N., Johansson M., Ståhlman M., Backhed F., Delzenne N.M., Schrenzel J., François P., Cani P.D. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J 2014, 8:2116-2130.
27. Ramirez-Farias C., Slezak K., Fuller Z., Duncan A., Holtrop G., Louis P. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 2009, 101:541-550.
28. Miquel S., Martin R., Bridonneau C., Robert V., Sokol H., Bermudez-Humaran L.G., Thomas M., Langella P. Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii. Gut Microbes 2014, 5:146-151.
29. Heinken A., Khan M.T., Paglia G., Rodionov D.A., Harmsen H.J.M., Thiele I. Functional metabolic map of Faecalibacterium prausnitzii, a beneficial human gut microbe. J Bacteriol 2014, 196:3289-3302.
30. Dewulf E.M., Cani P.D., Claus S.P., Fuentes S., Puylaert P.G., Neyrinck A.M., Bindels L.B., de Vos W.M., Gibson G.R., Thissen J.P., Delzenne N.M. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 2013, 6:1112-1121.
31. Subramanian S., Blanton L.V., Frese S.A., Charbonneau M., Mills D.A., Gordon J.I. Cultivating healthy growth and nutrition through the gut microbiota. Cell 2015, 161:36-48.
32. Trompette A., Gollwitzer E.S., Yadava K., Sichelstiel A.K., Sprenger N., Ngom-Bru C., Blanchard C., Junt T., Nicod L.P., Harris N.L., Marsland B.J. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014, 20:159-166.
33. Holscher J., Caporaso G., Hooda S., Brulc J.M., Fahey G.C., Swanson K.S. Fiber supplementation influences phylogenetic structure and functional capacity of the human intestinal microbiome: follow-up of a randomized controlled trial. Am J Clin Nutr 2015, 101:55-64.
34. Salonen A., Lahti L., Salojärvi J., Holtrop G., Korpela K., Duncan S.H., Date P., Farquharson F., Johnstone A.M., Lobley G.E., Louis P., Flint H.J., de Vos W.M. Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. ISME J 2014, 8:2218-2230.
35. Bindels L.B., Delzenne N.M., Cani P.D., Walter J. Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol 2015, 12:303-310.
36. Martinez I., Kim J., Duffy P.R., Schlegel V.L., Walter J. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS ONE 2010, 5:e15046.
37. Cotillard A., Kennedy S.P., Kong L.C., Prifti E., Pons N., Le Chatelier E., Almeida M., Quinquis B., Levenez F., Galleron N., Gougis S., Rizkalla S., Batto J.M., Renault P., MicroObes consortium A.N.R., Doré J., Zucker J.D., Clément K., Ehrlich S.D. Dietary intervention impact on gut microbial gene richness. Nature 2013, 500:585-588.
38. Kong L.C., Holmes B.A., Cotillard A., Habi-Rachedi F., Brazeilles R., Gougis S., Gausserès N., Cani P.D., Fellahi S., Bastard J.P., Kennedy S.P., Doré J., Ehrlich S.D., Zucker J.D., Rizkalla S.W., Clément K. Dietary patterns differently associate with inflammation and gut microbiota in overweight and obese subjects. PLOS ONE 2014, 9:e109434.
39. Hamaker B.R., Tuncil YE: A perspective on the complexity of dietary fiber structures and their potential effect on the gut microbiota. J Mol Biol 2014, 426:3838-3850.
40. Martens E.C., Lowe E.C., Chiang H., Pudlo N.A., Wu M., McNulty N.P. Recognition and degradation of plant cell wall polysaccharides by two human gut symbionts. PLoS Biol 2011, 9:e1001221.
41. Larsbrink J., Rogers T.E., Hemsworth G.R., McKee L.S., Tauzin A.S., Spadiut O., Klinter S., Pudlo N.A., Urs K., Koropatkin N.M., et al. A discrete genetic locus confers xyloglucan metabolism in select human gut Bacteroidetes. Nature 2014, 506:498-502.
42. Cuskin F., Lowe E.C., Temple M.J., Zhu Y., Cameron E.A., Pudlo N.A., Porter N.T., Urs K., Thompson A.J., Cartmell A., et al. Human gut Bacteroidetes can utilize yeast mannan through a selfish mechanism. Nature 2015, 517:165-169.
43. Rogowski A., Briggs J.A., Mortimer J.C., Tryfona T., Terrapon N., Lowe E.C., Baslé A., Morland C., Day A.M., Zheng H., Rogers T.E., Thompson P., Hawkins A.R., Yadav M.P., Henrissat B., Martens E.C., Dupree P., Gilbert H.J., Bolam D.N. Glycan complexity dictates microbial resource allocation in the large intestine. Nat Commun 2015, 6. In Press.
44. Ward R.E., Niñonuevo M., Mills D.A., Lebrilla C.B., German J.B. In vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Mol Nutr Food Res 2007, 51:1398-1405.
45. Shanahan F. Fiber man meets microbial man. Am J Clin Nutr 2015, 101:1-2.
46. Shanahan F., Quigley E.M.M. Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies. Gastroenterology 2014, 146:1554-1563.
47. Martens E.C., Kelly A.G., Tauzin A.S., Brumer H. The devil lies in the details: how variations in polysaccharide fine-structure impact the physiology and evolution of gut microbes. J Mol Biol 2014, 426:3851-3865.
48. Ze X., Duncan S.H., Louis P., Flint H.J. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J 2012, 6:1535-1543.
49. Scott K.P., Gratz S.W., Sheridan P.O., Flint H.J., Duncan S.H. The influence of diet on the gut microbiota. Pharmacol Res 2013, 69:52-60.
50. Everard A., Belzer C., Geurts L., Ouwerkerk J.P., Druart C., Bindels L.B., Guiot Y., Derrien M., Muccioli G.G., Delzenne N.M., de Vos W.M., Cani P.D. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 2013, 110:9066-9071.
51. Frese S., Mills D.A. Should infants cry over spilled milk? Fecal glycomics as an indicator of a healthy infant gut microbiome. J Pediatr Gastroenterol Nutr 2015, In press.
52. Vaillancourt J. Ending the war metaphor: the changing agenda for unraveling the host-microbe relationship. Regulating pre- and probiotics: a U.S. FDA perspective. Institute of Medicine of the National Academies 2006, 229-237. National Academies Press, Washington, DC.
53. van Loveren H., Sanz Y., Salminen S. Health claims in Europe: probiotics and prebiotics as case examples. Annu Rev Food Sci Technol 2012, 3:247-261.
54. FDA guidance for industry on complementary and alternative medicine products and their regulation by the food and drug administration 2006, http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM145405.pdf.
55. Kumar H., Salminen S., Verhagen H., Rowland I., Heimbach J., Banares S., Young T., Nomoto K., Lalonde M. Novel probiotics and prebiotics: road to the market. Curr Opin Biotechnol 2015, 32:99-103.
56. EFSA Scientific Opinion on the substantiation of health claims related to various food(s)/food constituents(s) and increasing numbers of gastro-intestinal microorganisms (ID 760, 761, 779, 780, 779, 1905), and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 760, 761, 779, 780, 779, 1905) pursuant to Article 13(1) of Regulation (EC) No 1924/20061. EFSA J 2010, 8:1809.
57. EFSA Scientific opinion on the substantiation of a health claim related to non-digestible carbohydrates and a reduction of post-prandial glycaemic responses pursuant to Article 13(5) of Regulation (EC) No 1924/20061. EFSA J 2014, 12:3513.
58. EFSA Scientific Opinion on the substantiation of a health claim related to "native chicory inulin" and maintenance of normal defecation by increasing stool frequency pursuant to Article 13.5 of Regulation (EC) No 1924/2006. EFSA J 2015, 13:3951.
59. Canada Food Inspection Agency. Health claims, use of the term "Prebiotic(s)". http://inspection.gc.ca/food/labelling/food-labelling-for-industry/healthclaims/eng/1392834838383/1392834887794?chap=10.
60. Japanese Ministry of Health, Labour and Welfare Food for Specified Health Uses (FOSHU) 2010, http://www.mhlw.go.jp/english/topics/foodsafety/fhc/02.html.
61. Zhang Y., Sun Y., Xie B. Quality of health information for consumers on the web: a systematic review of indicators, criteria, tools, and evaluation results. J Assoc Inf Sci Technol 2015.
62. Herbert V.G., Frings A., Rehatschek H., Gisbert R., Leithner A. Wikipedia challenges and new horizons in enhancing medical education. BMC Med Educ 2015, 15:32-37.
63. Van Loo J., Coussement P., DeLeenheer L., Hoebregs H., Smits G. On the presence of inulin and oligofructose as natural ingredients in the Western diet. Crit Rev Food Sci Nutr 1995, 35:525-552.
64. Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients 2013, 5:1417-1435.